In patients with metastatic progressive KIT-mutant GIST, tumor burden (as measured by the average diameter of the 3 largest lesions) was higher with detectable KIT ctDNA mutation than in those without (median, 5.97 cm vs. 2.40 cm, p = 0.0195) (Figure 2). This evidence concerns the gene KIT and gastrointestinal stromal tumor.